Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendations for Phase 1B Clinical Study of Phio S Lead Compound Ph-762
Phio Pharmaceuticals 宣布安全监测委员会对 Phio S 先导化合物 Ph-762 的 1B 期临床研究提出积极建议
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendations for Phase 1B Clinical Study of Phio S Lead Compound Ph-762
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.